Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Escalon Medical Corp.
  6. News
  7. Summary
    ESMC   US2960743050

ESCALON MEDICAL CORP.

(ESMC)
Delayed OTC Markets  -  12:03 2022-09-23 pm EDT
0.0930 USD    0.00%
09/28ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
09/28Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
05/13ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
SummaryQuotesChartsNewsCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2020

09/28/2020 | 04:02pm EDT

Escalon Medical Corp. announced earnings results for the full year ended June 30, 2020. For the full year, the company announced total revenue was USD 9.400 million compared to USD 9.626 million a year ago. Operating loss was USD 1.399 million compared to USD 252,955 a year ago. Net loss was USD 650,280 compared to USD 250,016 a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.04 a year ago.


© S&P Capital IQ 2020
All news about ESCALON MEDICAL CORP.
09/28ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
09/28Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2022
CI
05/13ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
05/13Escalon Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
02/14ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
02/14Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months En..
CI
2021ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
2021Escalon Medical Corp. Reports Earnings Results for the First Quarter Ended September 30..
CI
2021Escalon Medical : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2021Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2021
CI
More news
Financials (USD)
Sales 2022 10,7 M - -
Net income 2022 0,02 M - -
Net Debt 2022 0,61 M - -
P/E ratio 2022 -28,0x
Yield 2022 -
Capitalization 0,69 M 0,69 M -
EV / Sales 2021 0,16x
EV / Sales 2022 0,14x
Nbr of Employees 41
Free-Float 98,1%
Chart ESCALON MEDICAL CORP.
Duration : Period :
Escalon Medical Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Richard J. DePiano Chairman, President, CEO & General Counsel
Mark G. Wallace COO, Principal Financial & Accounting Officer
Lisa A. Napolitano Independent Director
C. Todd Trusk Independent Director
David James Jacovini Director
Sector and Competitors
1st jan.Capi. (M$)
ESCALON MEDICAL CORP.-13.48%1
THERMO FISHER SCIENTIFIC-22.39%202 880
DANAHER CORPORATION-19.08%193 675
INTUITIVE SURGICAL, INC.-46.45%68 708
BOSTON SCIENTIFIC CORPORATION-10.22%56 019
EDWARDS LIFESCIENCES CORPORATION-34.97%52 224